Align Technology, Inc. (BVMF:A1LG34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 64.34B +21.9% |
| Revenue (ttm) | 21.54B +4.4% |
| Net Income | 2.55B +30.0% |
| EPS | 9.47 +33.1% |
| Shares Out | n/a |
| PE Ratio | 23.71 |
| Forward PE | 14.13 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Open | 223.52 |
| Previous Close | 215.51 |
| Day's Range | 223.52 - 224.56 |
| 52-Week Range | 175.00 - 248.50 |
| Beta | 1.74 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |
About Align Technology
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. T... [Read more]
Financial Performance
In 2025, Align Technology's revenue was $4.03 billion, an increase of 0.90% compared to the previous year's $4.00 billion. Earnings were $410.35 million, a decrease of -2.61%.
Financial numbers in USD Financial StatementsNews
Align Technology Recognized in Extel's 2026 All-America Executive Team Rankings
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System ...
Align Technology announces $270M ASR agreement
Align Technology (ALGN) has entered into a new accelerated stock repurchase agreement with Goldman Sachs & Co. to repurchase $270M of Align’s common stock under Align’s $1B stock repurchase program…
Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, ...
Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ int...
Align Technology price target lowered to $210 from $215 at Leerink
Leerink lowered the firm’s price target on Align Technology (ALGN) to $210 from $215 and keeps an Outperform rating on the shares. The firm says there was a lot to…
Align Technology price target lowered to $175 from $188 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Align Technology (ALGN) to $175 from $188 and keeps an Equal Weight rating on the shares.
Align Technology Earnings Call Transcript: Q3 2026
Q3 revenue rose 1.9% as clear aligner shipments, doctor submitters and utilization reached records; non-GAAP operating margin improved to 24.4%. FY26 guidance reflects cautious demand and product mix, while management expects FY27 growth and margin expansion without a consumer recovery.
Align Technology Earnings release: Q3 2026
Align Technology released its Q3 2026 earnings on October 28, 2026, summarizing the period's financial results.
Align Technology Slides: Q3 2026
Align Technology has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 28, 2026.
Align Technology Quarterly report: Q3 2026
Align Technology has published its Q3 2026 quarterly earnings report on October 28, 2026.
Align Technology reports Q3 adjusted EPS $2.80, consensus $2.76
Reports Q3 revenue $1.015B, consensus $1B. Commenting on Align’s Q3’26 results, Align Technology (ALGN) President and CEO Joe Hogan said, “We delivered solid third-quarter results, with Q3 revenues an...
Align Technology sees Q4 revenue $1B-$1.02B, consensus $1.05B
Sees Q4 adjusted operating margin roughly 26%.
Align Technology sees FY26 revenue $4.11B-$4.13B, consensus $4.15B
Sees FY26 adjusted operating margin roughly 23.7%. Sees FY26 CapEx $125M-$150M.
Align Technology names Jennifer Davis president and CEO
Align Technology (ALGN) announced that its Board of Directors has appointed Jennifer L. Davis as the Company’s next President and Chief Executive Officer, effective December 31, 2026. Davis will succe...
Align Technology Announces Third Quarter 2026 Financial Results
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ int...
Align Technology Announces CEO Succession Plan
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures and sells the Invisalign® System of clear aligners, i...
Align Technology Commits Additional $1 Million to the American Association of Orthodontists Foundation to Support the Next Generation of Orthodontic Educators and Leaders
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ int...
Align Technology price target lowered to $200 from $220 at Mizuho
Mizuho lowered the firm’s price target on Align Technology (ALGN) to $200 from $220 and keeps an Outperform rating on the shares. The firm sees a “less optimistic” outlook for…
Align Technology price target lowered to $205 from $235 at Piper Sandler
Piper Sandler lowered the firm’s price target on Align Technology (ALGN) to $205 from $235 and keeps an Overweight rating on the shares. Clear aligner volumes measured across the firm’s…
Align Technology wins patent infringement case against Angelalign at UPC
Align Technology (ALGN) announces the decision of the Unified Patent Court, UPC, finding that aligner systems incorporating Angelalign’s (AGLFF) Torque Ridges feature infringe Align’s European Patent ...
Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court
SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System ...
Align Technology downgraded to Neutral from Outperform at Baird
Baird downgraded Align Technology (ALGN) to Neutral from Outperform with a price target of $162, down from $218.
Align Technology price target lowered to $215 from $235 at Leerink
Leerink lowered the firm’s price target on Align Technology (ALGN) to $215 from $235 and keeps an Outperform rating on the shares. The firm says there are very few expectations…
Align Technology price target lowered to $175 from $210 at Stifel
Stifel analyst Jonathan Block lowered the firm’s price target on Align Technology (ALGN) to $175 from $210 and keeps a Buy rating on the shares. U.S. Invisalign diligence is “weak”…
Align Technology downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Elizabeth Anderson downgraded Align Technology (ALGN) to In Line from Outperform with a price target of $155, down from $220. The firm cites a weakening consumer backdrop,…